Efficacy and Tolerability of Lacosamide in Pediatric and Young Adult Epilepsy Patients with Severe Motor and Intellectual Disabilities
LCM demonstrated good efficacy for intractable epilepsy in pediatric and young adult SMID patients. It was generally well-tolerated, resulting in a favorable retention rate. LCM emerged as a useful antiseizure medication for epilepsy treatment in pediatric and young adult SMID patients.
Authors
- Satoshi Goda (ORCID: https://orcid.org/0000-0003-0135-8701)
- Nobutsune Ishikawa (ORCID: https://orcid.org/0000-0003-2416-5697)
- Shin Suzuki (ORCID: https://orcid.org/0000-0002-5358-9619)
- Hiroki Izumo (ORCID: https://orcid.org/0000-0003-3907-9863)
- K Jinno
- Ayana Tsuboi
- Ryota Komori
Institutions
- Hiroshima Prefectural Hospital (JP)
Publication Details
- Journal
- Neuropediatrics
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1055/a-2508-5990
- Citations
- 1
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39